Abstract | BACKGROUND:
Tumoral calcinosis, an inherited metabolic disorder, has been described with increasing frequency over the last 20 years [Drueke 1966]. It is characterized by massive calcium phosphate deposits in periarticular tissues, usually around large joints, especially the hips, knees and elbows (editorial in Lancet 1987). PATIENT AND METHOD: CONCLUSION:
|
Authors | T Apostolou, M Tziamalis, C Christodoulidou, P Fountas, A Billis |
Journal | Clinical nephrology
(Clin Nephrol)
Vol. 50
Issue 4
Pg. 247-51
(Oct 1998)
ISSN: 0301-0430 [Print] Germany |
PMID | 9799070
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Hemodialysis Solutions
- Hydroxycholecalciferols
- Parathyroid Hormone
- Phosphates
- Calcium
- alfacalcidol
|
Topics |
- Calcinosis
(drug therapy)
- Calcium
(administration & dosage, analysis, blood)
- Chronic Kidney Disease-Mineral and Bone Disorder
(drug therapy)
- Hemodialysis Solutions
(administration & dosage, analysis)
- Humans
- Hydroxycholecalciferols
(administration & dosage, therapeutic use)
- Injections, Intravenous
- Ischium
(pathology)
- Kidney Failure, Chronic
(therapy)
- Male
- Middle Aged
- Parathyroid Hormone
(blood)
- Phosphates
(blood)
- Remission Induction
- Renal Dialysis
|